Similar articles

• Vigabatrin and epilepsy: lessons learned.

  Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E. Wild JM, et al. Epilepsia. 2007 Jul;48(7):1318-27. doi: 10.1111/j.1528-1167.2007.01133.x. Epilepsia. 2007. PMID: 17635558
• Visual field constriction on vigabatrin.

  [No authors listed] [No authors listed] Prescrire Int. 2000 Feb;9(45):210-1. Prescrire Int. 2000. PMID: 11503799
• [Changes in visual field of a child treatment with vigabatrin for 2 years].

  Mrugacz M, Bakunowicz-Łazarczyk A. Mrugacz M, et al. Klin Oczna. 2003;105(5):313-4. Klin Oczna. 2003. PMID: 14746187 Polish.
• [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].

  Mrugacz M, Bakunowicz-Łazarczyk A. Mrugacz M, et al. Klin Oczna. 2003;105(5):326-8. Klin Oczna. 2003. PMID: 14746191 Review. Polish.
• Vigabatrin-associated visual field loss.

  Fecarotta C, Sergott RC. Fecarotta C, et al. Int Ophthalmol Clin. 2012 Summer;52(3):87-94, xii. doi: 10.1097/IIO.0b013e31825a10a6. Int Ophthalmol Clin. 2012. PMID: 22668542 Review. No abstract available.